Lipella Pharmaceuticals I... (LIPO)

NASDAQ: LIPO · Real-Time Price · USD

2.50

-0.13 (-5.12%)

At close: Apr 29, 2025, 3:59 PM

2.45

-2.00%

After-hours: Apr 29, 2025, 04:00 PM EDT

Lipella Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-5.02M	-4.62M	-2.6M	-1.87M	-61.66K	-61.85K
Depreciation & Amortization	2.89K	1.69K	n/a	n/a	n/a	n/a
Stock-Based Compensation	749.4K	1.36M	747.4K	728.8K	57.71K	n/a
Other Working Capital	-136.94K	237.23K	-327.93K	175.25K	-7.48K	24.68K
Other Non-Cash Items	200K	121.2K	9.61K	-50.21K	7.64K	18.73K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	113.23K	-9.11K	9.52K	197.61K	-32.28K	14.34K
Operating Cash Flow	-3.95M	-3.15M	-1.83M	-989.27K	-28.58K	-39.12K
Capital Expenditures	n/a	-14.43K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	300.55M	-300.55K	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	300.55K	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-300.55M	-300.55K	n/a	n/a
Investing Cash Flow	n/a	-14.43K	300.55K	-300.55K	n/a	n/a
Debt Repayment	n/a	-275K	275K	n/a	57.04K	25K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.61M	n/a	n/a	n/a	n/a
Financial Cash Flow	2.84M	1.34M	5.24M	2.1M	609.31K	25K
Net Cash Flow	-1.11M	-1.83M	3.71M	807.09K	580.73K	-14.12K
Free Cash Flow	-3.95M	-3.16M	-1.83M	-989.27K	-28.58K	-39.12K